Yanli Yan

476 total citations
19 papers, 370 citations indexed

About

Yanli Yan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanli Yan has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yanli Yan's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). Yanli Yan is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). Yanli Yan collaborates with scholars based in China and United States. Yanli Yan's co-authors include Jinhua Tang, Shougang Zhuang, George Bayliss, Juan Ren, Xiaozhi Zhang, Rujun Gong, Beina Hui, Jiangzhou Zhang, Yinying Wu and Shuheng Bai and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yanli Yan

16 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Yan China 11 244 127 51 47 42 19 370
Xianqiu Zeng China 6 139 0.6× 51 0.4× 64 1.3× 15 0.3× 15 0.4× 6 305
Bridgit B. Bowskill Canada 10 237 1.0× 44 0.3× 29 0.6× 166 3.5× 28 0.7× 11 457
Tillmann Bork Germany 8 162 0.7× 26 0.2× 22 0.4× 162 3.4× 42 1.0× 10 450
Huanran Zhou China 9 217 0.9× 71 0.6× 10 0.2× 23 0.5× 21 0.5× 12 397
Daoyuan Lv China 9 229 0.9× 47 0.4× 33 0.6× 64 1.4× 35 0.8× 11 381
Christina Y.R. Tan Australia 10 231 0.9× 44 0.3× 9 0.2× 43 0.9× 23 0.5× 12 362
Gabin Sihn Germany 8 193 0.8× 25 0.2× 28 0.5× 41 0.9× 6 0.1× 10 399
Yideng Jiang China 12 239 1.0× 114 0.9× 10 0.2× 11 0.2× 14 0.3× 25 401
Sylviane Couette France 10 249 1.0× 31 0.2× 18 0.4× 115 2.4× 38 0.9× 13 455

Countries citing papers authored by Yanli Yan

Since Specialization
Citations

This map shows the geographic impact of Yanli Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Yan more than expected).

Fields of papers citing papers by Yanli Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Yan. The network helps show where Yanli Yan may publish in the future.

Co-authorship network of co-authors of Yanli Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Yan. A scholar is included among the top collaborators of Yanli Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Yan. Yanli Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yan, Yanli, et al.. (2025). GPR4 promotes immune exclusion in colon cancer through LOXL2-mediated extracellular matrix remodeling. Nature Communications. 17(1). 1196–1196.
2.
3.
4.
Hui, Beina, Shupei Pan, Shaomin Che, et al.. (2021). Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway. Cancer Management and Research. Volume 13. 4841–4852. 13 indexed citations
5.
Wu, Yinying, Bo Zhu, Yanli Yan, et al.. (2021). Long non‐coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR‐454 and ZEB1. Molecular Oncology. 15(5). 1584–1596. 24 indexed citations
6.
Wu, Yinying, Shuheng Bai, Yanli Yan, et al.. (2020). Long non‐coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer. Journal of Cellular and Molecular Medicine. 24(13). 7479–7489. 25 indexed citations
7.
Bai, Shuheng, Yinying Wu, Yanli Yan, et al.. (2020). Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma. Scientific Reports. 10(1). 13659–13659. 64 indexed citations
8.
Liu, Jiaxin, Zhao Liu, Xiaozhi Zhang, et al.. (2020). Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer. Cancer Cell International. 20(1). 342–342. 10 indexed citations
9.
Shao, Shuai, Yanli Yan, Si Yang, et al.. (2020). Association between G‑protein coupled receptor 4 expression and microvessel density, clinicopathological characteristics and survival in hepatocellular carcinoma. Oncology Letters. 19(4). 2609–2620. 9 indexed citations
10.
Wu, Yinying, Yanli Yan, Shuheng Bai, et al.. (2020). Downregulation of GPR4 and TCF7 Promotes Apoptosis and Inhibits Growth and Invasion of Ovarian Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry. 21(12). 1544–1550. 10 indexed citations
11.
12.
Yan, Yanli, Long Zhang, Li Tee Tan, et al.. (2018). Endocrine Therapy for Ductal Carcinoma In Situ (DCIS) of the Breast with Breast Conserving Surgery (BCS) and Radiotherapy (RT): a Meta-Analysis. Pathology & Oncology Research. 26(1). 521–531. 9 indexed citations
13.
Guo, Weina, Chunmei Wang, Hongqiang Li, et al.. (2018). [Evaluation value of human antibacterial peptide LL-37 on the prognosis of elderly patients with sepsis].. PubMed. 30(11). 1011–1016. 1 indexed citations
14.
Liu, Xiaoping, et al.. (2017). Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Biochemical and Biophysical Research Communications. 490(3). 1112–1118. 20 indexed citations
15.
Liu, Xiaoping, et al.. (2017). Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma. Journal of Biochemical and Molecular Toxicology. 31(12). 10 indexed citations
16.
Wang, Ji, Yi Li, Hongbing Ma, et al.. (2015). Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells. BioMed Research International. 2015. 1–12. 22 indexed citations
17.
Yan, Yanli, Jianwen Bai, Xiaoxu Zhou, et al.. (2015). P2X7 receptor inhibition protects against ischemic acute kidney injury in mice. American Journal of Physiology-Cell Physiology. 308(6). C463–C472. 68 indexed citations
18.
Tang, Jinhua, Yanli Yan, Ting C. Zhao, et al.. (2014). Class I HDAC activity is required for renal protection and regeneration after acute kidney injury. American Journal of Physiology-Renal Physiology. 307(3). F303–F316. 43 indexed citations
19.
Tang, Jinhua, Yanli Yan, Ting C. Zhao, et al.. (2013). Class I histone deacetylase activity is required for proliferation of renal epithelial cells. American Journal of Physiology-Renal Physiology. 305(3). F244–F254. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianqiu Zeng Breakdown of academic impact, for papers by Bridgit B. Bowskill Breakdown of academic impact, for papers by Tillmann Bork Breakdown of academic impact, for papers by Huanran Zhou Breakdown of academic impact, for papers by Daoyuan Lv Breakdown of academic impact, for papers by Christina Y.R. Tan Breakdown of academic impact, for papers by Gabin Sihn Breakdown of academic impact, for papers by Yideng Jiang Breakdown of academic impact, for papers by Sylviane Couette
Rankless by CCL
2026